Resultats de la cerca - X. Cynthia

Refinar resultats
  1. 1
    Letrozole in the neoadjuvant setting: the P024 trial

    Letrozole in the neoadjuvant setting: the P024 trial per Matthew J. Ellis, X. Cynthia

    Publicat 2007
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  2. 2
    Molecular Basis of Triple Negative Breast Cancer and Implications for Therapy

    Molecular Basis of Triple Negative Breast Cancer and Implications for Therapy per Parvin F. Peddi, Matthew J. Ellis, X. Cynthia

    Publicat 2011
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  3. 3
    Death by releasing the breaks: CHK1 inhibitors as cancer therapeutics

    Death by releasing the breaks: CHK1 inhibitors as cancer therapeutics per X. Cynthia, James W. Janetka, Helen Piwnica‐Worms

    Publicat 2010
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  4. 4
    Inhibition of cyclin dependent kinase 9 by dinaciclib suppresses cyclin B1 expression and tumor growth in triple negative breast cancer

    Inhibition of cyclin dependent kinase 9 by dinaciclib suppresses cyclin B1 expression and tumor growth in triple negative breast cancer per Sandeep Rajput, Nimmish Khera, Zhanfang Guo, Jeremy Hoog, Shunqiang Li, X. Cynthia

    Publicat 2016
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  5. 5
    Differences in the mutational landscape of triple-negative breast cancer in African Americans and Caucasians

    Differences in the mutational landscape of triple-negative breast cancer in African Americans and Caucasians per Foluso O. Ademuyiwa, Tao Yu, Jingqin Luo, Katherine N. Weilbaecher, X. Cynthia

    Publicat 2016
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  6. 6
    Breast cancer stage variation and survival in association with insurance status and sociodemographic factors in <scp>US</scp> women 18 to 64 years old

    Breast cancer stage variation and survival in association with insurance status and sociodemographic factors in <scp>US</scp> women 18 to 64 years old per Christine D. Hsu, Xiaoyan Wang, David V. Habif, X. Cynthia, Kimberly Johnson

    Publicat 2017
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  7. 7
    <i>HER2</i>-Mutated Breast Cancer Responds to Treatment With Single-Agent Neratinib, a Second-Generation HER2/EGFR Tyrosine Kinase Inhibitor

    <i>HER2</i>-Mutated Breast Cancer Responds to Treatment With Single-Agent Neratinib, a Second-Generation HER2/EGFR Tyrosine Kinase Inhibitor per Noa Ben-Baruch, Ron Bose, Shyam M. Kavuri, X. Cynthia, Matthew J. Ellis

    Publicat 2015
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  8. 8
    Combined Targeting of mTOR and AKT Is an Effective Strategy for Basal-like Breast Cancer in Patient-Derived Xenograft Models

    Combined Targeting of mTOR and AKT Is an Effective Strategy for Basal-like Breast Cancer in Patient-Derived Xenograft Models per Siguang Xu, Shunqiang Li, Zhanfang Guo, Jingqin Luo, Matthew J. Ellis, X. Cynthia

    Publicat 2013
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  9. 9
    Plasmodium falciparum erythrocyte membrane protein 1 is a parasitized erythrocyte receptor for adherence to CD36, thrombospondin, and intercellular adhesion molecule 1.

    Plasmodium falciparum erythrocyte membrane protein 1 is a parasitized erythrocyte receptor for adherence to CD36, thrombospondin, and intercellular adhesion molecule 1. per Dror I. Baruch, J A Gormely, X. Cynthia, R J Howard, B L Pasloske

    Publicat 1996
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  10. 10
    Association of PET-based estradiol-challenge test for breast cancer progesterone receptors with response to endocrine therapy

    Association of PET-based estradiol-challenge test for breast cancer progesterone receptors with response to endocrine therapy per Farrokh Dehdashti, Ningying Wu, X. Cynthia, Michael Naughton, John A. Katzenellenbogen, Barry A. Siegel

    Publicat 2021
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  11. 11
    Protein Subcellular Localization Profiling of Breast Cancer Cells by Dissociable Antibody MicroArray (DAMA) Staining

    Protein Subcellular Localization Profiling of Breast Cancer Cells by Dissociable Antibody MicroArray (DAMA) Staining per Fu, Guanyuan, Song, X. Cynthia, Yang, Xufen, Peng, Tao, Wang, Yingjian, Zhou, G. Wayne

    Publicat 2010
    Obtenir text complet Obtenir text complet Obtenir text complet
    Text
    Afegir a favorits
    Guardat en:
  12. 12
    Cost–effectiveness of CYP2B6 genotyping to optimize efavirenz dosing in HIV clinical practice

    Cost–effectiveness of CYP2B6 genotyping to optimize efavirenz dosing in HIV clinical practice per Schackman, Bruce R, Haas, David W, Park, Sanghee S, Li, X Cynthia, Freedberg, Kenneth A

    Publicat 2015
    Obtenir text complet Obtenir text complet Obtenir text complet
    Text
    Afegir a favorits
    Guardat en:
  13. 13
    US breast cancer mortality trends in young women according to race

    US breast cancer mortality trends in young women according to race per Foluso O. Ademuyiwa, Feng Gao, Hao Lin, Daniel Morgensztern, Rebecca Aft, X. Cynthia, Matthew J. Ellis

    Publicat 2014
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  14. 14
    Evaluation of Racial/Ethnic Differences in Treatment and Mortality Among Women With Triple-Negative Breast Cancer

    Evaluation of Racial/Ethnic Differences in Treatment and Mortality Among Women With Triple-Negative Breast Cancer per Beomyoung Cho, Yunan Han, Min Lian, Graham A. Colditz, Jason D. Weber, X. Cynthia, Ying Liu

    Publicat 2021
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  15. 15
    Neoadjuvant Chemotherapy Is Associated with Improved Survival Compared with Adjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer Only after Complete Pathologic Response

    Neoadjuvant Chemotherapy Is Associated with Improved Survival Compared with Adjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer Only after Complete Pathologic Resp... per Carla S. Fisher, X. Cynthia, William E. Gillanders, Rebecca Aft, Timothy J. Eberlein, Feng Gao, Julie A. Margenthaler

    Publicat 2011
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  16. 16
    Preclinical modeling of combined phosphatidylinositol-3-kinase inhibition with endocrine therapy for estrogen receptor-positive breast cancer

    Preclinical modeling of combined phosphatidylinositol-3-kinase inhibition with endocrine therapy for estrogen receptor-positive breast cancer per César Sánchez, X. Cynthia, Robert J. Crowder, Therese Guintoli, Chanpheng Phommaly, Feng Gao, Lin Li, Matthew J. Ellis

    Publicat 2011
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  17. 17
    Mammaglobin-A cDNA vaccination of breast cancer patients induces antigen-specific cytotoxic CD4+ICOShi T cells

    Mammaglobin-A cDNA vaccination of breast cancer patients induces antigen-specific cytotoxic CD4+ICOShi T cells per Venkataswarup Tiriveedhi, Timothy P. Fleming, Peter S. Goedegebuure, Michael Naughton, X. Cynthia, Craig Lockhart, Feng Gao, William E. Gillanders, T. Mohanakumar

    Publicat 2012
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  18. 18
    Risk of Breast Cancer With Prolactin Elevating Antipsychotic Drugs

    Risk of Breast Cancer With Prolactin Elevating Antipsychotic Drugs per Tahir Rahman, John M. Sahrmann, Margaret A. Olsen, Katelin B. Nickel, J. Philip Miller, X. Cynthia, Richard A. Grucza

    Publicat 2021
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  19. 19
    Acquired Fanconi syndrome is an indolent disorder in the absence of overt multiple myeloma

    Acquired Fanconi syndrome is an indolent disorder in the absence of overt multiple myeloma per X. Cynthia, Martha Q. Lacy, John F. Rompala, Angela Dispenzieri, S. Vincent Rajkumar, Philip R. Greipp, Rafaël Fonseca, Robert A. Kyle, Morie A. Gertz

    Publicat 2004
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  20. 20
    Endocrine Therapy With or Without Inhibition of Epidermal Growth Factor Receptor and Human Epidermal Growth Factor Receptor 2: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Fulvestrant With or Without Lapatinib for Postmenopausal Women With Hormone Receptor–Positive Advanced Breast Cancer—CALGB 40302 (Alliance)

    Endocrine Therapy With or Without Inhibition of Epidermal Growth Factor Receptor and Human Epidermal Growth Factor Receptor 2: A Randomized, Double-Blind, Placebo-Controlled Phase... per Harold J. Burstein, Constance Cirrincione, William T. Barry, Helen K. Chew, Sara M. Tolaney, Diana Lake, X. Cynthia, Kimberly Blackwell, Eric P. Winer, Clifford A. Hudis

    Publicat 2014
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:

Eines de cerca: